论文部分内容阅读
目的:观察和胃方Ⅱ号联合莫沙必利治疗糖尿病性胃肠病的临床疗效和复发率。方法:将80例符合标准的患者随机分为治疗组和对照组各40例。在糖尿病一般治疗的基础上,治疗组给予口服自拟中药和胃方Ⅱ号及莫沙必利,对照组仅给予莫沙必利,疗程4周,两组在服药期间均禁止服用其它治疗胃病的药物及影响疗效观察的药物,对两种疗法进行对比,计算各组临床有效率及评价胃固体半排空时间的改善情况;治疗结束后随访8周,观察患者有无病情复发。结果:两组症状较治疗前均改善(P<0.05),胃固体排空速度均加快(P<0.05)。治疗组胃肠病症状改善率明显优于对照组(P<0.05);治疗组胃排空速度改善明显优于对照组(P<0.01);治疗组复发率明显低于对照组(P<0.05)。结论:和胃方Ⅱ号联合莫沙必利可有效改善胃肠病症状,提高胃排空速度,减少复发率,效果优于单用传统促动力药莫沙必利。
OBJECTIVE: To observe the clinical efficacy and recurrence rate of “Hesifang No.2 combined with Mosapride” in the treatment of diabetic gastrointestinal disease. Methods: Eighty patients who met the criteria were randomly divided into treatment group (40 cases) and control group (40 cases). On the basis of the general treatment of diabetes, the treatment group was orally given self-made traditional Chinese medicine and stomach prescription No. 2 and mosapride, the control group only given mosapride, the course of treatment for 4 weeks, both groups were prohibited from taking other treatment of stomach during the medication Of the drugs and the effect of the observation of the drug, the two treatments were compared, the calculation of the clinical efficacy of each group and evaluation of gastric solid emptying time improvement; after treatment, followed up for 8 weeks to observe the patient with or without recurrence of the disease. Results: The symptoms of both groups were improved before treatment (P <0.05), and the gastric emptying rate was faster (P <0.05). The improvement rate of gastrointestinal symptoms in the treatment group was significantly better than that in the control group (P <0.05). The gastric emptying rate in the treatment group was significantly better than that in the control group (P <0.01), and the relapse rate in the treatment group was significantly lower than that in the control group ). Conclusion: Combined with Mosapride Ⅱ, Mosapride can effectively improve gastrointestinal symptoms, improve gastric emptying rate and reduce the recurrence rate, the effect is better than mosapride alone with traditional Chinese medicine.